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Abstract
Background: Uracil-DNA glycosylases (UDGs) catalyze excision of uracil from DNA. Vaccinia
virus, which is the prototype of poxviruses, encodes a UDG (vvUDG) that is significantly different
from the UDGs of other organisms in primary, secondary and tertiary structure and characteristic
motifs. It adopted a novel catalysis-independent role in DNA replication that involves interaction
with a viral protein, A20, to form the processivity factor. UDG:A20 association is essential for
assembling of the processive DNA polymerase complex. The structure of the protein must have
provisions for such interactions with A20. This paper provides the first glimpse into the structure
of a poxvirus UDG.
Results: Results of dynamic light scattering experiments and native size exclusion chromatography
showed that vvUDG is a dimer in solution. The dimeric assembly is also maintained in two crystal
forms. The core of vvUDG is reasonably well conserved but the structure contains one additional
β-sheet at each terminus. A glycerol molecule is found in the active site of the enzyme in both
crystal forms. Interaction of this glycerol molecule with the protein possibly mimics the enzyme-
substrate (uracil) interactions.
Conclusion:  The crystal structures reveal several distinctive features of vvUDG. The new
structural features may have evolved for adopting novel functions in the replication machinery of
poxviruses. The mode of interaction between the subunits in the dimers suggests a possible model
for binding to its partner and the nature of the processivity factor in the polymerase complex.
Background
Poxviruses are unique among DNA viruses in that their
entire life cycle, including DNA replication, occurs exclu-
sively within the cytoplasm of the host cell. Therefore, the
virus does not depend on cellular nuclear functions, and
relies largely on its own gene products for DNA replica-
tion, transcription and virion assembly. Proteins required
for DNA replication of poxvirus are thereby expressed
early in infection.
Vaccinia virus, the best characterized member of the
Orthopoxvirus family, is used as the smallpox vaccine. Its
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genome of ~200 kb encodes more than 200 proteins that
are highly conserved among poxviruses. The uracil-DNA
glycosylase (UDG), encoded by the D4 open-reading
frame (ORF), is essential for viral replication. Uracil resi-
dues are introduced into DNA either through misincorpo-
ration of dUTP by DNA polymerase or through
deamination of cytosine. In general, UDGs catalyze the
first step in the base excision repair pathway and remove
uracil residues from DNA by cleaving the glycosidic bond,
resulting in an apyrimidinic (AP) site. However, in poxvi-
rus UDG activity is rapidly induced following infection,
suggesting that the enzyme is required prior to and during
DNA synthesis [1]. Two observations have indicated the
involvement of vvUDG in DNA replication. The virus can-
not replicate in the absence of UDG [2], and two temper-
ature-sensitive (ts) mutations conferring defective DNA
replication map to the D4 ORF [3]. The first ts mutant,
Dts30 (ts4149), containing a G179R substitution was par-
tially impaired both in virus production and DNA replica-
tion at the permissive temperature (31.5°C) while it
displayed a strong DNA- phenotype at the non-permissive
temperature (39.7°C) [2]. The second ts mutant, Dts27
(ts3578), containing a L110F substitution showed normal
levels of DNA synthesis and virus production at 31.5°C
but DNA synthesis was essentially blocked at 39.7°C [2].
Additional support for the involvement of vvUDG in viral
replication comes from the discovery that vvUDG inter-
acts with another viral protein, A20 and forms the proces-
sivity factor [2]. The UDG:A20 complex (stoichiometry
1:1) binds to E9 (the catalytic subunit of DNA polymer-
ase) to assemble the processive DNA polymerase holoen-
zyme (stoichiometry of binding 1:1:1). The protein-
protein interaction between UDG and A20 is essential for
viral replication. However, this interaction does not
depend on the glycosylase activity or the presence of the
catalytic residues in UDG [4]. The interaction site on A20
has been mapped to its N-terminal 50 residues [5] but the
A20 binding site on UDG is not known.
The vvUDG enzyme is highly specific for uracil and pref-
erentially excises uracil when present in single stranded
DNA (ssDNA). Although viral UDG has a stronger affinity
for ssDNA (KM = 0.5 μM) than the human enzyme (KM =
2.9 μM), the excision efficiency of the human enzyme was
several orders of magnitude higher [1]. In the absence of
MgCl2 vaccinia virus and human nuclear UDG have com-
parable activity, but vvUDG is strongly inhibited in the
presence of MgCl2, while the human nuclear UDG shows
markedly enhanced activity. In addition, while the human
enzyme is strongly inhibited by the uracil-DNA glycosy-
lase inhibitor protein (Ugi) from Bacillus subtilis bacteri-
ophages PBS1 and PBS2, vvUDG shows no inhibition.
Overall the enzymatic properties of vvUDG differ from
the human enzymes suggesting a different mechanism of
action. Moreover, poxvirus UDGs exhibit low sequence
identity to other UDGs. Therefore, vvUDG may offer a
potential target for specific inhibitors.
Here, we describe the crystal structure of vvUDG in two
different crystal forms, and provide a comparison with the
most studied known UDG structures (human and E. coli).
These structures provide the first glimpse of a poxvirus
UDG and show unique features that distinguish the
enzyme from all other members of the UDG protein fam-
ily.
Results and discussion
vvUDG plays an essential role in viral replication as a
component of the DNA polymerase processivity factor.
The enzyme diverged significantly from UDGs of other
species in its primary, secondary and tertiary structure,
and through modifications of otherwise conserved active
site motifs.
vvUDG is a single-domain protein with 218 amino acids.
Results of size exclusion chromatography and dynamic
light scattering showed that in solution recombinant
vvUDG exists as a dimer of an estimated molecular weight
of 57 kDa.
UDGs of various members within the poxvirus family
show a high degree of sequence homology. UDGs from
the variola (smallpox) virus and vaccinia virus differ only
in 3 positions. Among all poxviruses, fowlpox UDG has
the lowest sequence identity (71%) with vvUDG. On the
other hand, sequence identity to UDGs from organisms
outside the poxvirus family is only about 20%.
Structure determination and quality
We have determined the crystal structure of recombinant
vvUDG by SIRAS phasing in trigonal space group P3221.
The structure was refined to an R value of 24.1% (Rfree of
29.9%) at 2.4 Å resolution (see Tables 1 and 2). The
recombinant protein used for crystallization contained an
N-terminal His-tag. The final model consists of two subu-
nits A and B with a total number of 440 protein residues
(subunit A: residues -1 to 171, 174 to 186 and 189 to 218;
B: -8 to 172, 174 to 186 and 189 to 218), 1 chloride and
1 sulfate ion, 146 water, 4 glycerol (GOL) and 3 imidazole
(IMD) molecules. Parts of the N-terminal His-tag are visi-
ble in both subunits, A (2 residues: -1 to 0) and B (9 resi-
dues: -8 to 0). Several residues in two loop regions could
not be fitted into the electron density in each subunit (A:
172,173, 187,188; B: 173, 187,188) presumably due to
disorder. In addition, some residues have truncated side
chain density in both subunits (A: -1, 0, 170, 171 and 195;
B: -8, -6, 0, 185 and 195). 3 residues in subunit B (S7, N17
and Q203) show alternate conformations. The Ramach-
andran plot shows 96.3% of all protein residues in the
allowed regions, with 12 residues (3.2%) in generouslyBMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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allowed and 2 residues (0.5%) in disallowed regions.
Electron density for several of the residues in generously
allowed regions (A9, Y11, F79 and N206 in both subu-
nits) and the two residues in the disallowed region (R167
and A168 in subunit B) is good. Of these residues A9 and
Y11 are part of a β-hairpin turn connecting strands 1 and
2. N206 is in the turn following helix 9 (residues 189–
205) in the C-terminal part of the protein. Refinement sta-
tistics are shown in Table 2.
We also crystallized vvUDG (without His-tag) in
orthorhombic space group P212121. This structure was
determined by molecular replacement using the refined
model of the trigonal crystal form, and was refined to an
R value of 25.3% (Rfree of 30.2%) at 2.3 Å resolution
(Tables 1 and 2). The final model consists of 8 subunits A
through H with a total number of 1708 residues (subunits
A: 214 residues; B: 212; C: 215; D: 215; E: 216; F: 214; G:
213; H: 209), 1 chloride ion, 573 water, 2 Hepes (EPE)
and 18 glycerol (GOL) molecules. Several residues in the
same two loop regions could not be fitted into the elec-
tron density in each subunit (A: 185–188; B: 168,169,
186–189; C: 187–189; D: 193–195; E: 185,186; F: 164,
165, 186,187; G: 188–192; H: 171–173, 185–190) and
are missing from the final model. The Ramachandran plot
shows 96.4% of all protein residues in allowed regions,
while 2.6% of the residues are found in generously
allowed and 1.2% (18 residues) in disallowed regions.
Here, the same residues (A9, Y11, F79 and N206) with
good electron density as mentioned for the trigonal crystal
form are also found in generously allowed and disallowed
regions. Refinement statistics are shown in Table 2. The
average rms deviation for all Cα atoms between subunits
of the two different crystal forms is ~0.5 Å.
Overall polypeptide fold
The overall structure of the vvUDG protein in both crystal
forms is similar. vvUDG adopts an α/β fold described as
DNA glycosylase fold in the SCOP database [6] that is
composed of a parallel β-sheet of 4 strands (order 2134)
with 3 layers of α/β/α. In Fig. 1 the secondary structure
assignments and topology diagrams for vvUDG are com-
pared with those for human UDG. In vvUDG the central
β-sheet is surrounded on either side by a total of 5 larger
helices. Two helices are observed on one side (residues:
45–49, 50–55; 188–205), and three helices on the other
side (residues: 19–32, 33–39; 86–101; 133–149). Addi-
tional features are seen at each terminus. At the N-termi-
nus the vvUDG structure exhibits a β-sheet made up of
two anti-parallel β-strands (residues: 1–7; 11–17). At the
C-terminus the polypeptide chain folds back to form
another small anti-parallel β-sheet (residues: 107–109;
215–217) and displays the pairing of two small helices
(residues: 110–113; 211–214). The active site groove is
visible at the C-terminal edge of the central parallel β-
sheet. Active site residues D68, Y70, F79, N120 and H181
are lined up at the edge of the groove. The tertiary struc-
ture of a vvUDG subunit is shown in Fig. 2A.
Assembly and protein-protein interactions
The asymmetric unit in trigonal space group P3221 con-
tains a dimer (type I) with subunits A and B related by
non-crystallographic symmetry two-fold symmetry (rms
deviation of 0.06 Å for all Cα atoms between individual
subunits). This NCS related dimer is shown in Fig. 2B. The
total buried solvent accessible surface area (SASA) is
approximately 4%, corresponding to an interface area of
806 Å 2 between individual subunits. Analysis of protein-
protein interactions was performed using the ProFace
server [7,8]. In each subunit there are 15 interface resi-
dues. For subunit B the contact area is confined to the N-
terminal residues 1–4, 6, 9–12 and 14, and residues 38,
45–47 and 54. For subunit A most of the interface residues
are found in two regions (residues: 54–56, 58–60; 111–
114) with a few additional residues at the termini (resi-
dues: 1–2, 16; 211, 214).
Table 1: Crystal data and data collection statistics for vvUDG.
Native I Native II Derivative (Uranyl)
Space Group P3221 P212121 P3221
Unit Cell Dimensions a = 85.20 Å
b = 85.20 Å
c = 139.72 Å
α = β = 90°, γ = 120°
a = 117.77 Å
b = 134.06 Å
c = 139.10 Å
α = β = γ = 90°
a = 85.15 Å
b = 85.15 Å
c = 139.53 Å
α = β = 90°, γ = 120°
Resolution Range 19.96–2.40 (2.48–2.40) 20.00–2.30 (2.38–2.30) 20.00–2.80 (2.97–2.80)
Total No. of Reflections 62227 733463 75084*
Unique Reflections 23203 98092 27719*
Average Redundancy 2.7 (2.7) 7.5 (7.5) 2.8 (2.8)
Completeness [%] 98.6 (99.5) 100.0 (100.0) 99.1 (99.8)
Reduced Chi Squared 0.99 (1.10) N/A N/A
Rmerge [%] 6.1 (29.9) 6.0 (25.3) 9.1 (34.2)
Mean I/σ(I) 11.0 (3.4) 10.4 (2.1) 11.3 (2.6)
The numbers in parentheses are for the highest-resolution shell.
* Friedel PairsBMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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The packing of vvUDG in the unit cell of the trigonal form
gives rise to a second type of dimer (type II) formed by
subunits that are related by crystallographic 2-fold sym-
metry. The buried surface area in these dimers amounts to
6.5–7% of the total SASA, corresponding to an interface
area of 1310 Å 2 between individual subunits. This type II
dimer interface has 16–18 residues (167–169; 175–178,
180; 190–191, 194–195, 198, 201–202, 204–206) from
each subunit. The contact residues are in the large con-
served C-terminal helix 9, the loop (residues 165–167)
connecting strands 8 and 9 and in strand 9. Since strand 9
is part of a conserved parallel β-sheet in the central core,
interactions involving this strand extend the four-
stranded β-sheet to an anti-parallel eight-stranded β-sheet
in the dimer. This type II dimer is also observed in the
orthorhombic space group P212121 (Fig. 2C), and is likely
the physiological dimer observed in solution. In the
orthorhombic crystal form, subunits A through H in the
asymmetric unit are arranged as four dimers related by
non-crystallographic 2-fold symmetry (rms deviation for
all Cα atoms between individual subunits is 0.39–0.45
Å). Based on the subunit-subunit interactions these dim-
ers are of type II as seen in the trigonal crystal form.
Considering that vvUDG is a dimer in solution (see Meth-
ods) the dimeric assembly in both crystal forms is unlikely
to be an artifact of crystal packing. The protein-protein
interactions in the dimers may be important in fulfilling
vvUDG's role as a component of the DNA polymerase
processivity factor. It is tempting to speculate that the
interactions in the type I dimer only seen in the trigonal
crystal form might mimic the interaction between UDG
and A20 in the heterodimeric complex (see later) while
the other set of interactions hold the homodimeric assem-
bly of vvUDG.
Active site
vvUDG was crystallized in the absence of any substrate.
Glycerol molecules from either the crystallization solu-
tion or the cryoprotecting reagent occupied the active site
in both crystal forms. The quality of electron density for
the active site residues and the glycerol molecules is excel-
lent in each case (see Omit Map; Fig. 3A). Glycerol is an
inhibitor of UDG and kinetic studies showed that 200
mM glycerol inhibited the reaction rate of E. coli UDG by
~50% [9]. A glycerol molecule (from the cryoprotectant)
was located in the uracil binding pocket in the crystal
structure of E. coli UDG [9]. In this structure the three
hydroxyl groups of glycerol mimicked atoms O2, O4, and
N3 of uracil (URA) in their interaction with the enzyme.
Glycerol forms hydrogen bonds directly or through water
molecules with active site residues (Q63, D64, Y66, F77,
Table 2: Refinement statistics for vvUDG.
PDB ID Trigonal (Native I) 2OWQ Orthorhombic (Native II) 2OWR
Resolution [Å] 19.27–2.40 (2.46–2.40) 20.00–2.30 (2.36–2.30)
No. of Reflections 21956 (1699) 93107 (7120)
Completeness [%] 98.4 (99.7) 99.9 (99.9)
Rall [%] 24.4 25.5
Rwork [%] 24.1 (29.5) 25.3 (28.3)




Ligands IMD, GOL, EPE 15, 24, NA NA, 108, 30
Ions Cl-, SO4
2- 1, 5 1, NA
Water 146 573
Wilson B-factor [Å 2] 35.0 26.0
Average B-factors [Å 2]
Overall 27.5 20.9
Protein 27.6 20.6
Ligands IMD, GOL, EPE 37.0, 33.0, NA NA, 30.6, 62.7
Ions Cl-, SO4
2- 43.7, 55.5 30.7, NA
Water 24.0 23.8
R.m.s. Deviations
Bonds [Å] 0.01 0.01
Angles [°] 1.13 1.33
Coordinate error ESU (max. likelihood) 0.26 0.21
Correlation Coefficient
FOFC 0.92 0.90
FOFC free 0.88 0.86
The numbers in parentheses are for the highest-resolution shell.BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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Protein sequence with secondary structure assignments and topology diagram for vvUDG and comparison with human UDG Figure 1
Protein sequence with secondary structure assignments and topology diagram for vvUDG and comparison 
with human UDG. (A) Wiring plot for vvUDG. The figure shows the protein sequence overlaid with assigned secondary 
structure elements for the vvUDG monomer. The β-strands are labeled B1 through B10 and α helices are labeled H1 through 
H10. A β-hairpin turn between the two N-terminal β-strands B1 and B2 is also shown. The portions of the missing loop 
regions are indicated by spaces. Several residues of the N-terminal His-tag are visible in the structure. (B) Topology diagram 
for vvUDG. There are a total of 4 β-sheets (β-sheet 1: strands 1 and 2; β-sheet 2: strands 3 and 7; β-sheet 3: strands 4, 6, 8 and 
9; β-sheet 4: strands 5 and 10). (C) Wiring plot for human UDG (PDBId: 1AKZ). The figure shows the protein sequence over-
laid with assigned secondary structure elements for human UDG. (D) Topology diagram for human UDG (PDBId: 1AKZ). The 
figure was prepared using the PDBSUM server [39, 40].BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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N123 and H187). In the vvUDG trigonal crystal form, one
glycerol molecule is located in the active site of subunit B
and occupies the same position as seen in E. coli UDG (see
Fig. 3B). This glycerol makes interactions with three of the
five active site residues (D68, F79 and N120) and their
immediate neighbors (see Fig. 3A). In subunit A an imida-
zole molecule occupies the active site making interactions
with D68 and displaying hydrophobic contacts with F79.
The chloride ion (Cl-) in subunit A shows distances of
3.3–3.5 Å to backbone nitrogen atoms of active site resi-
dues Y70 and F79 and the ND2 atom of N120. In subunits
A, C, E and G of the orthorhombic crystal form one glyc-
erol molecule is located in each active site and exhibits
similar interactions with active site residues D68, Y70, F79
Ribbon model of vvUDG Figure 2
Ribbon model of vvUDG. (A) Monomer of vvUDG. The figure depicts a ribbon model of vvUDG. The secondary structure 
elements are labeled according to Fig. 1A. Helices are labeled α1 through α10 and strands are marked β1 through β10. The 
active site residues are displayed as stick models. Positions of ts mutations are also shown as stick models (color code: purple). 
(B) Type I dimer of vvUDG. The figure shows the type I dimer of vvUDG as observed in the asymmetric unit of the trigonal 
crystal form. The subunits (A and B) in this dimer are related by NCS. Active site residues and ts mutation site residues are 
shown as stick models as seen in (A). (C) Type II dimer of vvUDG. The figure shows the type II dimer of vvUDG. These dim-
ers are observed in the asymmetric unit of the orthorhombic crystal form (subunits related by NCS) and also in the unit cell of 
the trigonal crystal form (subunits related by crystallographic symmetry). The active site residues are displayed as stick models. 
Positions of ts mutations are also shown as stick models (color code: purple).BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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and N120 as described for subunit B of the trigonal crystal
form. Details of the contacts involving these ligands in
both crystal forms are listed in Table 3.
Figure 3 shows a comparison of the active sites of vvUDG
(with bound glycerol) and E. coli UDG complexes (with
bound glycerol and uracil). We have modeled a uracil
molecule in the active site of vvUDG in an orientation as
found in other crystal structures (Fig. 3C).
In both crystal forms additional glycerol molecules are
located away from the active site. Contacts formed by
non-active site glycerol molecules and other ligands are
provided in Additional file 1.
Variations in active site motifs
The vvUDG sequence exhibits considerable differences in
the characteristic motifs utilized by other UDGs for recog-
nizing and flipping the uracil moiety in the substrate DNA
during the catalytic activity (see Table 4 for a comparison
of motifs in vvUDG with E. coli and human UDG). The
vvUDG has five of the six conserved active site residues
(D68, Y70, F79, N120 and H181), but lacks the conserved
Leu residue (see Table 4). In other UDGs the Leu residue
is part of the 'Leu intercalation loop', which has the char-
acteristic motif (-HPSPLSXXR-). The 'intercalation loop'
(also called catalytic loop) is substantially altered in pox-
virus UDGs (see Table 4). Only 3 residues (H181, P182
and R187) match with residues in human and E. coli
UDG. Residue R185 in vvUDG corresponds to L191 in E.
coli UDG (see Fig. 4A).
Uracil DNA glycosylase catalyzes the hydrolytic cleavage
of the N-glycosidic bond of premutagenic uracil residues
in DNA by base flipping. Results from a study by Drohat
et al. [10] in E. coli support a mechanism for catalysis that
emphasizes catalytic residue Asp64 as the general base
activating a water molecule for nucleophilic attack at C1'
of the deoxyribose, and catalytic residue His187 as a neu-
tral electrophile, stabilizing a developing negative charge
on uracil atom O2 in the transition state. Stivers et al. [11]
demonstrated that base flipping contributes little to the
free energy of DNA binding but provides a substantial
contribution to specificity through an induced-fit mecha-
nism. For the binding of DNA substrates UDG uses a
number of residues that are not part of the active site [12].
According to Tainer et al. [13-15] the DNA repair mecha-
nism of UDG involves pinching of the phosphodiester
backbone of damaged DNA using hydroxyl side chains of
four conserved serine residues (S88, S166, S189 and S192
in E. coli UDG; S169, S247, S270 and S273 in human
UDG). This results in flipping of the deoxyuridine from
the DNA helix into the enzyme active site. These authors
propose that strain induced by serine pinching is used to
lower the activation barrier for glycosidic bond cleavage.
Results based on S88A, S189A, and S192G "pinching"
mutations described by Werner et al. [16] indicated a role
for these serine-phosphodiester interactions in uracil flip-
ping and preorganization of the sugar ring into a reactive
conformation. The 'Pro-rich' and 'Gly-Ser' loops that con-
tain Ser residues in other UDGs are missing in vvUDG. In
addition, the two Ser residues are also missing from the
'Leu intercalation loop' (see Table 4). In the pinch-push-
pull uracil detection mechanism, the conserved Leu resi-
due of the 'Leu intercalation loop' penetrates into the
DNA minor groove to push the uracil base into the active-
site pocket. Based on the structure of the L272A complex
of human UDG with DNA, the L272 side chain push is
not essential for nucleotide flipping, although it plays a
key role in efficient activity [13]. Results of another study
Table 3: Major contacts of ligands with protein residues and 
water molecules at the active site.
2OWQ:
Ligand Atom Residue Atom Distance (Å)
GOL301 X O3 D68 B O 3.37
GOL301 X O3 Wat146 O 2.83
GOL301 X O1 N120 B ND2 3.21
GOL301 X O1 Wat132 O 2.62
GOL301 X O1 N120 B OD1 2.86
GOL301 X O1 F79 B N 2.91
Cl201 X CL Wat134 O 3.43
Cl201 X CL N120 A ND2 3.26
Cl201 X CL Y70 A N 3.47
Cl201 X CL F79 A N 3.35
IMD401 X N1 D68 A O 3.28
2OWR:
Ligand Atom Residue Atom Distance (Å)
GOL605 O1 Y70 A N 2.99
GOL605 O2 F79 A N 2.77
GOL605 O2 N120 A OD1 2.33
GOL605 O2 N120 A ND2 3.05
GOL612 O1 N120 C ND2 2.85
GOL612 O3 G76 C O 2.71
GOL616 O1 Y70 E N 3.07
GOL616 O1 Wat166 O 3.03
GOL616 O2 N120 E OD1 2.38
GOL616 O2 N120 E ND2 2.99
GOL616 O2 F79 E N 2.65
GOL619 O1 N120 G OD1 2.69
GOL619 O1 N120G ND2 2.84
GOL619 O3 D68 G O 2.62
GOL619 O3 N120 G OD1 3.01
Cl600 CL N120 C N 3.13
Cl600 CL N120 C O 2.70
Cl600 CL GOL612 O2 2.46BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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Superimposition of vvUDG and E. coli UDG: Close-up view of the active site Figure 3
Superimposition of vvUDG and E. coli UDG: Close-up view of the active site. The figure shows a close-up view of 
the active site of vvUDG and E. coli UDG. The two structures were superimposed with TOPP [22]. (A) Active site of vvUDG. 
The active site of vvUDG with the glycerol (GOL) molecule at the center is shown in this stereo figure. The difference elec-
tron density for glycerol (Fo-Fc omit map contoured at 3σ) is displayed (blue mesh). A second glycerol molecule away from the 
active site can also be seen. Active site residues are shown as stick models. (B) Active site of E. coli UDG (3EUG). Shown is a 
close-up view of the active site in E. coli UDG in the same orientation as the vvUDG in Fig. 3A. The bound glycerol (GOL) in 
the active site is shown in the center. Active site residues are shown as stick models. (C) Active site of vvUDG with modeled 
uracil. The active site of vvUDG was superimposed on the E. coli UDG active site containing uracil. The uracil molecule (URA) 
is modeled into the active site of vvUDG in the same position and orientation as seen in Fig. 3D for the E. coli structure 
(2EUG). The carbonyl oxygen atoms of uracil in this model superimpose with two hydroxyl groups in glycerol in the vvUDG 
structure. (D) Active site in E. coli UDG (2EUG). Shown is a close-up view of the active site in E. coli UDG with a bound uracil 
(URA) molecule in the same orientation as in Figs. 3A and 3B.BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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[17] suggest that the Leu residue within the -HPSPLS-
motif is crucial for the uracil excision activity of UDG.
The side chain of this conserved Leu residue in UDG is
also inserted into the hydrophobic cavity of the specific
uracil-DNA glycosylase inhibitor (Ugi) from Bacillus subti-
lis [18,19]. Putnam et al. [18] pointed out that a signifi-
cant fraction of the buried surface area (~10%) in the Ugi-
complex results from the complementarity between the
conserved Leu residue and the Ugi hydrophobic cavity.
Poxvirus UDGs contain instead an Arg residue at this posi-
tion in the 'Leu intercalation loop' (see Fig. 4A). It was
Comparison of 'Leu intercalation' loops in vvUDG and E. coli UDG Figure 4
Comparison of 'Leu intercalation' loops in vvUDG and E. coli UDG. This figure shows a structural comparison of the 
'Leu intercalation' loops in vvUDG and E. coli UDG and provides a model for the lack of inhibition of vvUDG by Ugi. (A) Super-
imposition of 'Leu intercalation' loops. The two superimposed loops are shown in different colors (vvUDG cyan; E. coli UDG 
green). L191 in E. coli UDG (green) and the corresponding residue R185 in vvUDG (cyan) are shown as stick models. Other 
loop residues are also shown and some of the loop residues are labeled. It can be seen that only the two N-terminal loop res-
idues, Pro (vvUDG P182; E. coli UDG P188) and His (vvUDG H181; E. coli UDG H187), are identical in sequence and in similar 
orientations. (B) Close-up view of UDG:Ugi complex. The structure of vvUDG was superimposed onto the E. coli UDG struc-
ture in the UDG:Ugi complex. For the UDG proteins only the loop regions are shown (E. coli UDG in green, vvUDG in cyan), 
while for Ugi the semi-transparent surface of the binding pocket is shown (colored by element). The eight hydrophobic resi-
dues of Ugi (M24, V29, V32, I33, V43, M56, L58 and V71) that form the hydrophobic cavity and provide major interactions with 
the 'Leu intercalation' loop in E. coli UDG [19] are shown as stick models. The corresponding residues in the 'Leu intercalation' 
loop, L191 in E. coli UDG (green) and R185 in vvUDG (cyan), are shown as stick models. In E. coli UDG:Ugi complex L191 
points into the hydrophobic pocket.
Table 4: Characteristic motifs in UDGs (Example: E. coli UDG [2EUG] and human UDG [1AKZ]) and variations as seen in vvUDG 
(2OWQ, 2OWR).
2EUG 1AKZ 2OWQ, 2OWR
Catalytic water- 62-GQDPYH-67 143-GQDPYH-148 66-GIDPYP-71
activating-loop
Pro-rich loop 84-AIPPS-88 165-PPPPS-169 -
Uracil specificity 120-LLLN-123 201-LLLN-204 117-IPWN-120
Gly-Ser loop 165-GS-166 246-GS-247 -
Leu intercalation loop 187-HPSPLSAHR-195 268-HPSPLSVYR-276 179-GYHPAARDR-187
Active site residues D64, Y66, F77, N123, H187, L191 D145, Y147, F158, N204, H268, L272 D68, Y70, F79, N120, H181BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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shown that vvUDG activity is not inhibited by Ugi [3].
Superimposition of vvUDG with E. coli UDG in the E. coli
UDG-Ugi inhibitor complex (1UUG) provides a possible
explanation for the lack of inhibition (Fig. 4B). Size and
electrostatic property of the Arg residue are incompatible
with insertion into the hydrophobic cavity of Ugi.
Since the conserved Leu residue and the 'Leu intercalation
loop' are critical components for the conventional UDG
catalytic mechanism, poxvirus UDGs may utilize a differ-
ent yet unknown reaction mechanism for carrying out the
DNA repair activity.
The conserved motif for uracil specificity (-LLLN-) in
UDGs is also altered in the vvUDG protein (-IPWN-).
Only N120 as part of the active site residues is conserved.
Nonetheless, poxvirus UDG is still highly specific for
uracil and does not act on other modified bases [1]. In
addition, the 'catalytic water-activating loop' is different
in vvUDG. This loop (-GIDPYP-) shows two changes com-
pared to the conserved motif (-GQDPYH-).
Discussion of the temperature-sensitive Mutants (Dts27 
and Dts30)
Two temperature sensitive mutants, which were mapped
to the D4 ORF by Ellison et al. [3], have been described.
Of these, Dts30 (G179R substitution), is of particular
interest since this mutation confers defective DNA replica-
tion and demonstrates a reduced ability of the mutant D4
protein to interact with A20. Residue G179 is the C-termi-
nal residue of strand 9 in the central parallel β-sheet. As
shown in Fig. 5 the substitution of G179 residue by an Arg
residue (modeled) would force a large basic residue into
the hydrophobic pocket made up of residues Y156, I177,
F195 and I198. Y156 is part of the preceding strand 8,
I177 is part of strand 9, while F195 and I198 belong to
helix 9 following strand 9. Accommodating the side chain
of Arg179 will require considerable structural rearrange-
ment. It is likely, although speculative, that the mutation
leads to a rearrangement of secondary structure elements
(β-strands and α-helices) at and close to the C-terminus to
accommodate this residue, which in turn might interfere
with binding to A20 and the formation of the A20:UDG
Model for temperature-sensitive mutant (Dts30) of vvUDG Figure 5
Model for temperature-sensitive mutant (Dts30) of vvUDG. This figure shows a close-up view of the protein region 
for the G179R substitution in the temperature-sensitive mutant Dts30 and shows the effect of the mutation. (A) Residues in 
this pocket are displayed as stick models and are labeled. (B) The pocket is shown in the same view as in Fig. 5A, but an Arg 
residue (color code: pink) in one rotamer conformation was modeled in place of G179 to indicate that a substitution at this 
position will introduce steric hindrance. In addition, other rotamer conformations that point towards residues F195 and I198 
will position this charged residue even farther into the hydrophobic pocket. In the shown conformation, distances of side chain 
atoms of the modeled R179 are only 1.5–2.5 Å from surrounding residues.BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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processivity factor. Another possibility is a destabilizing
effect of this mutation by modulating the dimer interface
resulting in a potential interference with the dimer forma-
tion.
The other temperature-sensitive mutation, Dts27, creates a
L110F substitution. Although this residue points into a
hydrophobic pocket formed by residues F79, I89, I92 and
Y108, the bulky aromatic side chain of the mutated resi-
due is expected to cause steric hindrance and disrupt the
local environment as shown in the model in Fig. 6.
Structural comparison to other UDG structures
vvUDG shows ~20% sequence identity with E. coli and
human UDGs. Sequence homology with herpes simplex
virus1 (HSV1) UDG is also in the same range (21% iden-
tity). The structural homology between these proteins is
low (rms deviation of 2.0 Å for 149 Cα atoms and a match
rate of 66% to vvUDG). On the other hand, HSV1 UDG is
very similar to human UDG and E. coli UDG in terms of
sequence (39% identical to human; 49% identical to E.
coli), fold (rms deviation of 1.1 Å for 210 Cα atoms and a
match rate of 94% to human; rms deviation of 1.2 Å for
199 Cα atoms and a match rate of 88% to E. coli) and
characteristic motifs [20,21].
The core of the vvUDG structure, however, is similar to
other UDGs. The conserved four-stranded central parallel
β-sheet, a small second β-sheet made from two anti-paral-
lel β-strands, and six helices in the vvUDG structure match
with the observed topology in E. coli and human UDG
(see Table 5). Superimposition of the vvUDG structure
with E. coli UDG (PDBId: 2EUG) using program TOPP
[22] revealed an rms deviation of 2.1 Å for 136 Cα atoms
in the matching secondary structure elements (match rate
64.5%; sequence identity 21.3%). The superimposition
with human UDG (PDBId: 1AKZ) gave an rms deviation
of 2.0 Å for 138 Cα atoms in the matching secondary
structure elements (match rate 61.9%; sequence identity
20.3%). The vvUDG structure shows some new features
that are unique among known UDG structures as dis-
cussed earlier and shown in Fig. 1. Compared to vvUDG
the C-termini in E. coli [9] and human [23] UDG do not
show any well defined secondary structure. Other struc-
tural differences of vvUDG to E. coli and human UDG
include fewer α-helices surrounding the central β-sheet, a
distinct bend of the N-terminal helix (residues 19–39),
some tighter turns in loop regions and the movement of
C-terminal residues in strands 8 and 9. These two strands
are shifted towards the center of the parallel β-sheet with
respect to the other two structures.
Model for temperature-sensitive mutant (Dts27) of vvUDG Figure 6
Model for temperature-sensitive mutant (Dts27) of vvUDG. This figure shows a close-up view of the protein region 
for the L110F substitution in the temperature-sensitive mutant Dts27 and shows the effect of the mutation. (A) Residues in 
this pocket are displayed as stick models and are labeled. (B) The pocket is shown in the same view as in Fig. 6A, but a Phe res-
idue (color code: pink) in a preferred rotamer conformation was modeled in place of L110 to indicate that a substitution at this 
position will introduce steric hindrance. In this conformation, distances of side chain atoms of the modeled F110 are only 2.6–
2.8 Å from side chain atoms of I89 and I92.BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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Model for processivity factor Figure 7
Model for processivity factor. This figure shows the potential function of vvUDG as a sliding clamp as part of the viral 
processivity factor and compares the model with the sliding clamp from S. solfataricus. (A) A model of the proposed sliding 
clamp. Shown is a homotetrameric arrangement of two dimers as observed in both crystal structures of vvUDG. The diameter 
of the central channel is 27 Å. N-terminal residues 1–16 and C-terminal residues 208–218 that are part of the first dimer inter-
face (see Fig. 2B) and implicated in potential binding to A20 are shown and highlighted (purple). The straight line passing 
through the central channel indicates a DNA molecule. The possible binding site for A20 is shown. (B) Model of proposed slid-
ing clamp shown as molecular surface colored by electrostatic potential (color code: red electronegative; blue electropositive; 
white neutral). The view is the same as in Fig. 7A. The electrostatic potential for the highlighted residues in Fig. 7A indicates 
neutral regions in these locations. (C) Sliding clamp in S. solfataricus (2IX2) [25]. The heterotrimeric sliding clamp PCNA in S. 
solfataricus is shown as ribbon model (color code: by chain). The diameter of the central channel is 29 Å.BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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A structure-based alignment of UDG sequences that
included also the vvUDG sequence [13] demonstrates the
pitfalls of this approach when the sequence identity drops
to about 20%. The new features especially at the termini
are not recognized, and the corresponding residues in the
viral sequence are instead lined up with the previously
observed conserved secondary structure elements in
UDGs of other species. It is intuitive that the described
novel features in the vaccinia virus UDG structure play a
role in the unique function of poxvirus UDG in replica-
tion.
A plausible model for the function of poxvirus UDG as
part of the processivity factor is shown in Fig. 7. The
model shows two dimers arranged around a central chan-
nel in a homotetrameric arrangement that is observed in
both crystal structures (Figs. 7A and 7B). A similar molec-
ular assembly has been noticed in previously studied slid-
ing clamps [24-26]. The diameter of the central channel in
vvUDG is approximately 27 Å (distance measured
between corresponding residues on either side). This
compares well with diameters in the heterotrimeric slid-
ing clamp of PCNA (Fig. 7C) in Sulfolobus solfataricus
(PDBId: 2IX2) and the homodimeric sliding clamp of the
polymerase β-subunit in E. coli (PDBId: 1MMI) that are
~29 Å and 30–35 Å, respectively. However, the central
channel must have sufficient flexibility in order to accom-
modate various binding components. In this analogy
A20, which acts as a scaffold with binding regions for
UDG, E9 and other factors such as D5 and H5 [5], would
seem to function as a clamp loader. Protein regions at the
type I dimer interface only observed in the trigonal crystal
form may be involved in the binding of A20. A part of this
dimer interface includes N-terminal residues 1–16 and C-
terminal UDG residues 208–218. These 27 residues are
almost exclusively hydrophobic. Interestingly, the N-ter-
minal 50 residues of A20 that constitute the minimal
interacting binding site for UDG are also predominantly
hydrophobic. A hydrophobic interaction in the proposed
binding surface is consistent with the observed stability of
the heterodimeric A20:UDG complex at high ionic
strength (up to 750 mM NaCl) [2]. Although previous
experiments have suggested a 1:1 stoichiometry of bind-
ing between A20 and UDG [2], the true composition of a
functional polymerase unit remains to be determined.
Conclusion
To our knowledge, vaccinia virus UDG is the only known
dimeric protein of this class. We propose that the
observed molecular assembly may be related to its cellular
functions, which include its role in DNA repair and inter-
action with one or more binding partners. These interac-
tions are essential to the formation of the processive DNA
polymerase needed for the replication of the virus. Dis-
covering tools to disrupt these associations will have tre-
mendous impact in the field of antiviral therapy of
poxvirus infection. The structures described here offer a




The D4 gene sequence (AAA48100; Western Reserve 109)
encoding for uracil-DNA glycosylase (218 a.a.; Mr ~25
kDa) was subcloned into pET15b vector (Novagen), and
transformed into E. coli BL21(DE3)pLysS Rosetta cells
(Invitrogen). DNA sequencing showed a single substitu-
tion (D17N) when compared to the vaccinia virus
sequence in the database. The resulting recombinant pro-
tein contains a 20-residue insert at the N-terminus com-
prising of a hexahistidine tag and a thrombin cleavage
site. Bacterial cells were grown in Luria-Bertani (LB) broth
in the presence of ampicillin to an OD595 of 0.7 at 37°C.
After induction by isopropyl-β-D-thiogalactopyranoside
(IPTG) the protein was expressed for 16 hrs at 18°C. The
cell culture was centrifuged at 6400 g for 15 min at 4°C,
and cell pellets were stored at -80°C until further use.
Purification
Frozen cells suspended in a lysis buffer (50 mM Tris, pH
8.0; 100 mM NaCl; 1 mM benzamidine; 0.1 mM phenyl-
methylsulfonyl fluoride; 5 mM β-mercaptoethanol) were
lysed by multiple cycles of freezing and thawing. The cell
free extract was prepared by centrifugation at 39200 g for
30 min at 4°C. The recombinant protein was purified
from the bacterial extract using affinity chromatography
on a Ni-NTA column (Amersham Biosciences). After the
protein was eluted from the column with 200 mM imida-
zole, the hexahistidine tag was removed by treatment with
thrombin. The digestion mixture was concentrated and
subjected to gel filtration on a Superdex 200 column
equilibrated with elution buffer (50 mM Tris, pH 9.0; 100
Table 5: Matching secondary structure elements between E. coli 
UDG (2EUG), human UDG (1AKZ) and vvUDG (2OWQ, 
2OWR).
2EUG 1AKZ 2OWQ, 2OWR
Helix 2, 3 18–31 99–116 19–32, 33–39
Strand 3 36–38 117–119 41–43





Strand 4 57–62 138–143 61–66
Helix 6 86–100 167–181 86–101
Helix 7 111–117 192–198 110–113
Strand 6 118–124 199–205 115–121
Strand 7 128–130 209–211 125–127
Helix 8 140–156 221–237 133–149
Strand 8 159–164 240–245 153–159
Strand 9 181–185 262–266 175–179
Helix 9 201–212 282–294 189–205BMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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mM NaCl; 3 mM dithiothreitol). The major portion of the
protein eluted as a dimer (calculated from the elution vol-
ume of protein standards and from dynamic light scatter-
ing experiments). Fractions representing this major peak
were concentrated to 8 mg/ml by ultrafiltration.
We also employed a rapid single step affinity purification
protocol using a TALON™ (BD Biosciences) column for
purification of His-tagged protein from the bacterial
extract. Briefly, the cell free extract (pH 7.3) was applied to
the TALON™ column containing immobilized cobalt
ions. The column was extensively washed with buffer con-
taining 300 mM NaCl and 5 mM imidazole. The tightly
bound protein was eluted in a gradient at about 150 mM
imidazole in Tris buffer (50 mM, pH 7.3; 100 mM NaCl;
10 mM β-mercaptoethanol). According to the SDS poly-
acrylamide gel the protein purity was better than 95%.
The N-terminal His-tag was not cleaved, and protein in
the peak fractions was concentrated to approximately 7
mg/ml without buffer exchange.
Crystallization and data collection
The thrombin cleaved protein crystallized in two different
conditions (condition 1: 5% PEG6000, 7.5% MPD, 0.1 M
Hepes, pH 7.25 at 4°C; condition 2: 5% PEG3000, 0.1 M
NaCl, 0.1 M Hepes, pH 7.5 at 4°C). Crystals grew to about
0.2–0.3 mm in 1–3 days. These crystals belong to
orthorhombic space group P212121 with unit cell dimen-
sions of a = 117.77 Å, b = 134.06 Å, c = 139.10 Å (see
Table 1). In this crystal form, there are 8 subunits of UDG
in the asymmetric unit (VM ~2.7 Å 3/Da corresponding to
55% solvent). Results from dynamic light scattering (DLS)
verified that the protein exists predominantly as a dimer
(estimated MW ~57 kDa, Stokes radius ~3.4 nm).
The protein purified in the one-step procedure without
buffer exchange (pH 7.3) was crystallized in 100 mM
Hepes buffer, pH 7.25, 12% glycerol and 1.5 M ammo-
nium sulfate as precipitant. The size and quality of crystals
were significantly improved using a microseeding proto-
col (2 μl drops with a 1:1 ratio of protein to seed solution)
using the hanging-drop vapor diffusion experiment in
NeXtal plates (QIAGEN). The protein crystallized in trigo-
nal space group P3221 with unit cell parameters of a = b =
85.20 Å, c = 139.72 Å, γ = 120° (see Table 1). The asym-
metric unit contains two subunits related by non-crystal-
lographic symmetry (VM ~2.7 Å 3/Da corresponding to
54% solvent).
Heavy-atom derivatives were prepared by transferring
crystals from seeding experiments into a stabilizing solu-
tion (100 mM Hepes buffer at pH 7.25, 12% glycerol and
1.7 M ammonium sulfate) containing in addition varying
amounts (1–5 mM) of different heavy atom salts. In this
fashion, we obtained successfully a uranyl derivative from
an overnight soak in 3 mM uranyl nitrate, which contains
U+4 ions in form of the bivalent radical UO2
2+ group. The
dataset of this heavy-atom derivative was isomorphous to
the dataset of the native protein with slightly different unit
cell parameters (see Table 1). Data were collected at 100 K
on cryoprotected (same as crystallization solution but
with 25% glycerol) crystals in house (R-Axis IV image
plate detector) and at BioCryst (R-Axis IV++).
Glycerol was used as cryoprotectant for both crystal forms.
For the trigonal form crystals were transferred directly
from the crystallization condition (containing 12% glyc-
erol) into the same solution with 25% glycerol, while for
the orthorhombic form cryoprotection required a step-
transfer protocol (5% to 25% glycerol). All diffraction
data were indexed and processed using HKL2000 [27] and
DTREK [28] program packages. Diffraction data are sum-
marized in Table 1.
Structure solution
Efforts to solve the structure by molecular replacement
using known UDG structures of E. coli, human and herpes
simplex virus failed. The structure of vvUDG in trigonal
space group P3221 was determined using SHELX [29] by
the method of single isomorphous replacement with
anomalous scattering (SIRAS) with phase information
from a single heavy atom derivative (see Table 1). Isomor-
phous (to the native dataset) and anomalous differences
of the uranyl dataset were good to 2.8 Å resolution. With
the help of the graphical interface "hkl2map" determina-
tion of the heavy atom substructure (U sites) and initial
phasing was successful at 2.8 Å using SHELXD [30]. A cor-
relation coefficient of 46% between Eobs values (from ΔF)
and Ecalc values (from heavy atoms) indicated an excellent
quality of this solution. The proper enantiomorph and the
right space group (P3221) were clearly established. After
density modification and phase extension to 2.5 Å resolu-
tion in SHELXE [31] the SIRAS phases for space group
P3221 had an overall figure of merit of 0.60 and a connec-
tivity index of 0.91.
The structure of the orthorhombic crystal form was solved
by molecular replacement with the program MOLREP
[32] using the refined model of the trigonal crystal form.
The structure solution shows eight subunits in the asym-
metric unit arranged as 4 homodimers.
Model building and refinement
The obtained reflection file with SIRAS phases was con-
verted to CCP4 mtz format. The resultant map allowed the
placement of 59% of the amino acid sequence into the
electron density by automated model building using PHE-
NIX [33], and clearly established the presence of the two
expected subunits in the asymmetric unit. The remaining
residues were fitted into electron density maps calculated
with combined SIRAS and model phases. Manual model
building was performed with QUANTA (Accelrys, Inc.)
and COOT [34]. Model building and stages of subsequent
refinement included the use of CNS [35] simulatedBMC Structural Biology 2007, 7:45 http://www.biomedcentral.com/1472-6807/7/45
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annealing omit maps. This procedure was especially nec-
essary to follow the chain correctly in the regions of the
dimer interfaces because of the close proximity of NCS
and symmetry related molecules, and also because these
regions contain the residues that are disordered in the
final model. In addition, the use of omit maps and differ-
ence electron density maps was standard practice through-
out model building and refinement. Ligands and water
molecules were added using programs CNS [35], REFMAC
[36] and COOT [34] and also manually into difference
electron density maps (Fo-Fc maps, 3σ level). All water
molecules that showed low occupancies or high B-factors
after refinement and did not satisfy distance constraints
for hydrogen-bonding to protein residues were subse-
quently removed. For the ligands the real space R fit and
the quality of electron density was the deciding factor.
Refinement for the trigonal crystal form (subunits A, B)
was carried out at 2.4 Å resolution using CNS [35] and
REFMAC [36]. Various NCS models (from tight NCS to no
NCS) were used during refinement stages. The final NCS
restraints produced the lowest Rfree and the smallest differ-
ence between R and Rfree values. In addition to restrained
refinement by maximum likelihood with tight NCS
restraints for main chain atoms (rms  deviation of dis-
tances is 0.18 Å and of B-factors is 0.29 Å 2) and medium
NCS restraints for side chain atoms (rms deviation of dis-
tances is 0.50 Å and of B-factors is 0.44 Å 2), we also used
the TLS refinement option in REFMAC [36]. Each protein
subunit (subunits A and B) was divided into three TLS
groups (residues 1–97, 98–162 and 163–218) based on
analysis by the TLS motion determination (TLSMD) server
[37]. Release of NCS restraints and independent refine-
ment of subunits led to an increase in R values and wors-
ened the geometry.
Refinement for the orthorhombic crystal form was carried
out at 2.3 Å resolution using CNS [35] and REFMAC [36].
Restrained refinement by maximum likelihood with
medium NCS restraints was combined with TLS refine-
ment in REFMAC [36].
Table 2 shows the refinement statistics for both structures.
Figures were prepared using PyMOL (DeLano Scientific
LLC) and GRASP [38].
Coordinates and structure factors for the trigonal and
orthorhombic crystal forms of vvUDG have been depos-
ited in PDB (PDBIds: 2OWQ, 2OWR).
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